Home > > North America And Global Gamma Oryzanol Market- Size, Share, Growth Rate, and Forecast
The North America Gamma Oryzanol market was valued at $30.5 Million in 2023, and is projected to reach $37.3 Million by 2030 growing at a CAGR of 2.97% from 2024 to 2030. Sports Supplements segment is expected to be the highest contributor to this market, with $14.3 Million in 2023, and is anticipated to reach $16.8 by 2030, registering a CAGR of 2.41%. Pharmaceuticals segment is anticipated to reach $3.1 Million by 2030 with the highest CAGR of 4.42%. Sports Supplements and Animal Feed segments collectively expected to account for about 76.7% share of the North America Gamma Oryzanol market in 2023, with the former constituting around 46.7% share. Pharmaceuticals and Animal Feed segments are expected to witness significant growth rates at a CAGR of 4.42% and 3.89% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 37.6% in the overall North America Gamma Oryzanol market in 2023, and is anticipated to reach 40.4% by 2030. Application Sports Supplements Cosmetics Pharmaceuticals Animal Feed BY REGION North America U.s. Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan South Korea India Indonesia Rest of Asia Middle East & Africa Brazil Mexico South Africa Australia Rest of MENA